| Allen Ryves Moore, MD | |
|
100 Baptist Memorial Cir Ste 330, Oxford, MS 38655-4477 | |
| (662) 767-4200 | |
| (662) 767-4204 |
| Full Name | Allen Ryves Moore |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 100 Baptist Memorial Cir Ste 330, Oxford, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225471246 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Memorial Hospital North Ms | Oxford, MS | Hospital |
| Baptist Memorial Hospital - Calhoun, Inc. | Calhoun city, MS | Hospital |
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Baptist Memorial Hospital Union County | New albany, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Specialty Orthopedic Group Of Mississippi Pllc | 3577878883 | 28 |
News Archive
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
Researchers from the Moscow Institute of Physics and Technology have published a review on serial femtosecond crystallography, one of the most promising methods for analyzing the tertiary structure of proteins.
Wanted: stems cells. Just like those absconders chased by police all over the world, everybody can tell about their good deeds but none really knows how to recognize them.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
› Verified 6 days ago
| Entity Name | Specialty Orthopedic Group Of Mississippi Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639553506 PECOS PAC ID: 3577878883 Enrollment ID: O20150817000322 |
News Archive
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
Researchers from the Moscow Institute of Physics and Technology have published a review on serial femtosecond crystallography, one of the most promising methods for analyzing the tertiary structure of proteins.
Wanted: stems cells. Just like those absconders chased by police all over the world, everybody can tell about their good deeds but none really knows how to recognize them.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allen Ryves Moore, MD 1211 S Gloster St Ste A, Tupelo, MS 38801-6548 Ph: (662) 767-4200 | Allen Ryves Moore, MD 100 Baptist Memorial Cir Ste 330, Oxford, MS 38655-4477 Ph: (662) 767-4200 |
News Archive
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
Researchers from the Moscow Institute of Physics and Technology have published a review on serial femtosecond crystallography, one of the most promising methods for analyzing the tertiary structure of proteins.
Wanted: stems cells. Just like those absconders chased by police all over the world, everybody can tell about their good deeds but none really knows how to recognize them.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
› Verified 6 days ago
Wayne Terry Lamar, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2168 S Lamar Blvd, Oxford, MS 38655 Phone: 662-234-8432 Fax: 662-234-5267 | |
Robert Tyler Ellis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 497 Azalea Dr Ste 102, Oxford, MS 38655 Phone: 662-513-2000 | |
Cooper Loomis Terry, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 497 Azalea Dr, Suite 102, Oxford, MS 38655 Phone: 662-513-2000 Fax: 662-513-2001 | |
Dr. William Clayton Hopper Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 21015 Will's Trace, Oxford, MS 38655 Phone: 901-239-4864 | |
Dr. Elvis Jeff Justis Jr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 710 Longmeadow Drive, Oxford, MS 38655 Phone: 662-236-2940 Fax: 662-236-2940 | |
Dr. Major Benjamin Burch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 497 Azalea Dr Ste 102, Oxford, MS 38655 Phone: 662-513-2000 |